Enanta Pharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Enanta Pharmaceuticals by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $56k | 6.2k | 9.00 |
2023-09-30 | $56k | 5.0k | 11.17 |
2023-06-30 | $524k | 25k | 21.40 |
2022-12-31 | $38k | 816 | 46.54 |
2022-09-30 | $96k | 1.9k | 51.55 |
2022-06-30 | $97k | 2.1k | 46.43 |
2022-03-31 | $1.2M | 17k | 71.15 |
2021-12-31 | $1.6M | 22k | 73.53 |
2021-09-30 | $597k | 16k | 38.46 |
2021-06-30 | $910k | 21k | 44.05 |
2021-03-31 | $207k | 4.2k | 49.35 |
2020-12-31 | $1.8M | 42k | 42.10 |
2020-09-30 | $1.9M | 41k | 45.81 |
2020-06-30 | $2.1M | 42k | 50.19 |
2020-03-31 | $1.8M | 34k | 51.42 |
2019-12-31 | $2.0M | 32k | 61.79 |
2019-09-30 | $1.8M | 30k | 60.05 |
2019-06-30 | $2.4M | 29k | 84.38 |
2019-03-31 | $2.6M | 27k | 95.55 |
2018-12-31 | $2.0M | 28k | 70.82 |
2018-09-30 | $2.1M | 24k | 85.48 |
2018-06-30 | $5.0M | 43k | 115.89 |
2018-03-31 | $2.0M | 25k | 80.92 |
2017-12-31 | $1.4M | 23k | 58.69 |
2017-06-30 | $479k | 13k | 35.95 |
2017-03-31 | $660k | 21k | 30.84 |
2016-12-31 | $393k | 12k | 33.52 |
2016-09-30 | $171k | 6.5k | 26.54 |
2016-06-30 | $1.8M | 80k | 22.10 |
2016-03-31 | $2.4M | 81k | 29.30 |
2015-12-31 | $3.0M | 90k | 32.99 |
2015-09-30 | $1.3M | 37k | 36.13 |
2015-03-31 | $1.0M | 34k | 30.59 |
2014-12-31 | $2.6M | 51k | 51.28 |
2014-06-30 | $1.1M | 27k | 43.05 |
2014-03-31 | $2.2M | 54k | 40.94 |
2013-12-31 | $857k | 31k | 27.29 |
2013-09-30 | $398k | 17k | 22.92 |